11:37 AM EDT, 08/25/2025 (MT Newswires) -- The Dow Jones and the S&P 500 stock indexes were down, while the Nasdaq Composite was up in late-morning trading Monday after Federal Reserve Chair Jerome Powell indicated on Friday in his Jackson Hole, Wyoming speech that the central bank could begin easing monetary policy next month.

In company news, Keurig Dr Pepper ( KDP ) has agreed to acquire JDE Peet's for 15.7 billion euros ($18.37 billion) in cash, the companies said Monday. After the expected H1 2026 deal close, Keurig Dr Pepper ( KDP ) plans to separate into two US-listed companies, with one focused on refreshment beverages and the other as a pure-play coffee company. Under the deal terms, Keurig Dr Pepper ( KDP ) will pay JDE Peet's shareholders 31.85 euros per share in cash. Keurig Dr Pepper ( KDP ) shares were down 7.9% around midday.

Tesla (TSLA) Chief Executive Elon Musk sued Apple ( AAPL ) and Microsoft ( MSFT )-backed (MSFT) OpenAI on Monday in federal court in Texas for allegedly illegally conspiring to curb artificial intelligence competition, according to media reports. Apple ( AAPL ) shares were up 0.5%, Microsoft ( MSFT ) was flat and Tesla was up 1% around midday.

Intel ( INTC ) said Monday in a regulatory filing that the US government's acquisition of a 9.9% stake in the company could pose risks to its business, including by impacting its non-US sales and limiting its ability to secure future government grants. Intel ( INTC ) shares were up 1.4%.

Verint Systems ( VRNT ) said Monday it will be acquired by Thoma Bravo for $2 billion in an all-cash deal. Verint ( VRNT ) said shareholders will receive $20.50 per share, an 18% premium over its 10-day average share price before reports of a sale. The deal is expected to close by the end of Verint's ( VRNT ) current fiscal year, the company said. Verint ( VRNT ) shares were down 1.2%.

Crescent Energy ( CRGY ) and Vital Energy ( VTLE ) have entered into a definitive agreement under which Crescent will acquire Vital for around $3.1 billion in an all-stock deal, the companies said Monday. Under the terms of the transaction, which is expected to close by the end of the year, Vial shareholders will receive 1.9062 shares of Crescent class A common stock for each Vital share owned. Crescent shares were down 6.3%, while those of Vital were up 12.9%.

AbbVie ( ABBV ) has agreed to buy Gilgamesh Pharmaceuticals' bretisilocin for up to $1.2 billion, including an upfront payment and development milestones, the companies said Monday. As part of the deal, Gilgamesh will spin off an entity to be called Gilgamesh Pharma to hold its employees and other programs, including an ongoing collaboration and option-to-license agreement with AbbVie ( ABBV ) to develop psychiatric disorder treatments, the companies said. AbbVie ( ABBV ) shares were down 0.9%.

Price: 32.35, Change: -2.79, Percent Change: -7.94